Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Family physicians and other primary care providers don’t mind being held to account for care quality by healthcare administrators. The rub is that multiple other stakeholders often demand similar levels of answerability, pulling the doctors in different directions at once.
Pharmaceutical companies are spending close to $10 billion per year on direct-to-consumer advertising in the U.S. Only the entertainment industry spends more. Is that a good thing?
The idea was floated as part of a proposed budget for the state released by Democrats in the Senate. If passed, only the top 2% of corporations in California would be impacted. The levy would generate $5 billion to $8 billion annually for Medicaid.
The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments.
Aidence will license, develop, and validate Google Health’s existing AI research module, hoping to offer better differentiation between benign and malignant lung nodules at an early stage.
Also worth a look: the ACR Data Science Institute’s AI Central, updated this week with detailed information on imaging AI products that have been cleared by the FDA.
A university in the Lone Star State is readying a master’s degree program that will prepare grad students to work as radiologic “techs” in all 50 states.
Three and a half weeks after abruptly closing shop due to unspecified technical difficulties, Hawaii Radiologic Associates is reopening its doors in stages.
Cloud giant Amazon Web Services is expanding its 1½ -year-old HealthLake data-management service in two imaging-specific directions. In the process it’s drawing vocal buy-in from healthcare providers as well as imaging vendors.